Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Account Payables (2024 - 2025)

Connect Biopharma Holdings' Change in Account Payables history spans 2 years, with the latest figure at -$300000.0 for Q3 2025.

  • For Q3 2025, Change in Account Payables fell 104.08% year-over-year to -$300000.0; the TTM value through Sep 2025 reached $1.6 million, changed N/A, while the annual FY2024 figure was -$1.9 million, 64.35% down from the prior year.
  • Change in Account Payables for Q3 2025 was -$300000.0 at Connect Biopharma Holdings, down from $1.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.5 million in Q2 2025 and bottomed at -$1.8 million in Q1 2024.